AzTrials
AzTrials

Food AddictionFAST - FRNCT04126239

Validation of a Food Addiction Screening Test

An observational study of Food Addiction and Obesity, run by Hospices Civils de Lyon at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Food addiction (FA) is a behavioral addiction characterized by a high consumption of palatable foods, which markedly activate the reward system, despite adverse consequences. FA was first described in 1956 but remains controversial. The Yale Food Addiction Scale (YFAS), developed by Gearhardt et al. Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Food Addiction, Obesity
What is being tested?
Online survey - questionnaire
How many people
1,610 participants
Where
1 siteFrance
Study dates
7 Oct 2019to 17 Jun 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: * BMI ≥ 30 * Able to consent

Who may be able to join

  • BMI ≥ 30
  • Able to consent

Who cannot join

  • Non-french speaker
  • Patient unable to use internet tools

Trial locations and contacts

1 site in 1 country.

Emmanuel Disse, PR contact

emmanuel.disse@chu-lyon.fr

France1 site, 1 recruiting
  • Centre Hospitalier Lyon Sud

    Pierre-Bénite

    Sylvain ICETA, MD

    Emmanuel DISSE, PR

    Recruiting

Other trials in France

About this study

Official title: Validation Study of a Rapid Screening Test of Food Addiction in Patients Suffering From Obesity and Healthy Volunteer

Food addiction (FA) is a behavioral addiction characterized by a high consumption of palatable foods, which markedly activate the reward system, despite adverse consequences. FA was first described in 1956 but remains controversial. The Yale Food Addiction Scale (YFAS), developed by Gearhardt et al. in 2009, is currently regarded as the "Gold Standard" for FA screening. In a previous study, we established a Food Addiction Screening Test using artificial intelligence. The main objective of the present study is to validate the sensitivity, specificity and precision for FA diagnosis in a sample of patient suffering from obesity and healthy volunteers.

Being tested
Online survey - questionnaire
Keywords
food Addiction, Obesity
Medical subject headings
Food Addiction, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Online survey - questionnaireOther

    Online survey - questionnaire

Study groups in NCT04126239
Study groupRoleWhat they receive
Participant suffering from obesityPatient, male or female, over 18 and under 70 years old Patient group with a Body Mass Index (BMI) greater than or equal to 30 kg / m2
Receives: Other: Online survey - questionnaire
healthy volunteerNot described
Receives: Other: Online survey - questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. FAST score

    Screening test to validate

    Measured: Baseline

  2. YFAS 2.0

    Screening test to validate DSM-5 Yale Food Addiction Scale (YFAS 2.0)

    Measured: Baseline

  3. BES score

    Binge Eating Scale scoring

    Measured: Baseline

  4. DEBQ score

    Dutch Eating Behaviour Questionnaire scoring

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Oct 2019
  2. Study start7 Oct 2019
  3. Primary completion17 Oct 2022 (estimated)
  4. Study completion17 Jun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
1,610 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04126239
Sponsor's protocol ID
69HCL19_0320
Acronym
FAST - FR
Status last verified
Jun 2021
First submitted
11 Oct 2019
Last updated
18 Jun 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Food Addiction and Obesity, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Sylvain ICETA, MD (4 27 85 60 11 ext. +33, sylvain.iceta@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

FAST score (time frame: Baseline). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in